Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 31, 2013
Reporting Period: The filing references financial results for the three and six months ended June 30, 2013, announced via press release on August 1, 2013.
Key Financial Metrics
This Form 8-K serves as a notification of events and does not contain specific financial data tables. The filing states that financial results for the three and six months ended June 30, 2013, are detailed in a press release furnished as Exhibit 99.1. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in the text of this filing.
Material Changes and Corporate Events
- Spin-off Filing: On July 31, 2013, the Company's wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, Inc., filed a Form 10 Registration Statement with the SEC.
- Strategic Intent: The Form 10 filing is in connection with the Company's intended spin-off of its regenerative medicine device business.
- Financial Results Announcement: The Company announced its financial results for the period ended June 30, 2013, on August 1, 2013.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, or management commentary regarding future performance. It notes that the information in Item 2.02 and the attached exhibits shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that section, except as expressly set forth by specific reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 1, 2013) for specific revenue, earnings, and cash flow figures for the three and six months ended June 30, 2013.
- Examine Exhibit 99.2 (Press Release dated July 31, 2013) for details regarding the spin-off of the regenerative medicine device business.
- Locate the Form 10 Registration Statement filed by Harvard Apparatus Regenerative Technology, Inc., to understand the structure and timeline of the intended spin-off.
- Verify the status of the spin-off transaction and any potential impact on the parent company's capital structure or operations.